Kolli CS - Search Results

1

Stability-indicating HPLC assay for lysine-proline-valine (KPV) in aqueous solutions and skin homogenates.

Pawar KR, Mulabagal V, Smith F, Kolli CS, Rangari VK, Babu RJ. Pawar KR, et al. Among authors: kolli cs. Biomed Chromatogr. 2015 May;29(5):716-21. doi: 10.1002/bmc.3347. Epub 2014 Oct 9. Biomed Chromatogr. 2015. PMID: 25298219

2

Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin.

Pawar K, Kolli CS, Rangari VK, Babu RJ. Pawar K, et al. Among authors: kolli cs. J Pharm Sci. 2017 Jul;106(7):1814-1820. doi: 10.1016/j.xphs.2017.03.017. Epub 2017 Mar 24. J Pharm Sci. 2017. PMID: 28343991

3

Effect of lipophilicity on microneedle-mediated iontophoretic transdermal delivery across human skin in vitro.

Pawar KR, Smith F, Kolli CS, Babu RJ. Pawar KR, et al. Among authors: kolli cs. J Pharm Sci. 2013 Oct;102(10):3784-91. doi: 10.1002/jps.23694. Epub 2013 Aug 17. J Pharm Sci. 2013. PMID: 23955316

4

Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate.

Kolli CS, Xiao J, Parsons DL, Babu RJ. Kolli CS, et al. Drug Dev Ind Pharm. 2012 May;38(5):571-6. doi: 10.3109/03639045.2011.617753. Epub 2011 Oct 8. Drug Dev Ind Pharm. 2012. PMID: 21980925

5

Transdermal iontophoretic delivery of selegiline hydrochloride, in vitro.

Kolli CS, Chadha G, Xiao J, Parsons DL, Babu RJ. Kolli CS, et al. J Drug Target. 2010 Nov;18(9):657-64. doi: 10.3109/10611860903494237. J Drug Target. 2010. PMID: 20038213

6

Characterization of solid maltose microneedles and their use for transdermal delivery.

Kolli CS, Banga AK. Kolli CS, et al. Pharm Res. 2008 Jan;25(1):104-13. doi: 10.1007/s11095-007-9350-0. Epub 2007 Jun 28. Pharm Res. 2008. PMID: 17597381

7

In vitro transdermal delivery of therapeutic antibodies using maltose microneedles.

Li G, Badkar A, Nema S, Kolli CS, Banga AK. Li G, et al. Among authors: kolli cs. Int J Pharm. 2009 Feb 23;368(1-2):109-15. doi: 10.1016/j.ijpharm.2008.10.008. Epub 2008 Oct 19. Int J Pharm. 2009. PMID: 18996461

8

Enhanced transdermal delivery of low molecular weight heparin by barrier perturbation.

Lanke SS, Kolli CS, Strom JG, Banga AK. Lanke SS, et al. Among authors: kolli cs. Int J Pharm. 2009 Jan 5;365(1-2):26-33. doi: 10.1016/j.ijpharm.2008.08.028. Epub 2008 Aug 29. Int J Pharm. 2009. PMID: 18801420

9

Microneedles: bench to bedside.

Kolli CS. Kolli CS. Ther Deliv. 2015;6(9):1081-8. doi: 10.4155/tde.15.67. Epub 2015 Sep 30. Ther Deliv. 2015. PMID: 26419290 Review.

10

Characterization of microchannels created by metal microneedles: formation and closure.

Kalluri H, Kolli CS, Banga AK. Kalluri H, et al. Among authors: kolli cs. AAPS J. 2011 Sep;13(3):473-81. doi: 10.1208/s12248-011-9288-3. Epub 2011 Jul 6. AAPS J. 2011. PMID: 21732220 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters